The Science of Biologics and Biosimilars: Why Proteins Are Different

Bloomberg BNA's Pharmaceutical Law and Industry Report publishes "The Science of Biologics and Biosimilars: Why Proteins Are Different," coauthored by Scientific Advisor Laurence Borden and Partner Daniel Reisner.